Wahyuni Wahyuni

Mrs. Wahyuni Wahyuni


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2021 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
WWWahyuni Wahyuni
Wahyuni Wahyuni
ADAjeng Diantini
Ajeng Diantini
MGMohammad Ghozali
Mohammad Ghozali
ASAnas Subarnas
Anas Subarnas
EJEuis Julaeha
Euis Julaeha
ISIdin Sahidin
Idin Sahidin
Etlingera alba is one of the Etlingera plants that might have anticancer activity. This study aims to investigate the cytotoxic and antimetastatic activity of E. alba rhizome fractions and migration cell assay against MDA-MB-231 cell lines, which are used for triple-negative breast cancer (TNBC) treatment assay. The cytotoxic activity was assayed using CCK-8 assay, while the antimetastatic was assayed using migration cell assay for the fractions AF. They were followed by LCMS/MS profiling to determine the chemical contents in the most active fraction. According to results obtained, fraction B was the most active fraction for cytotoxic activity with an IC50 value of 65.43μg/mL, while fraction E was the most active fraction for antimetastasis activity against migration rate doses of 50, 100, and 200ppm which were 6.80, 3.66, and 3.00, respectively. Several compounds in fraction B, such as rengyolone, licochalcone A, sugiol, and spinasterol, might have been known to have activity against cancer cells, as well as aschantin and lirioresinol B dimethyl ether from fraction E. In conclusion, the chemical components from E. alba rhizome fractions provided potency for discovering new agents for cancer treatment, specifically for TNBC.

24 September 2024 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
WWWahyuni Wahyuni
Wahyuni Wahyuni
FMFadhliyah Malik
Fadhliyah Malik
APAsniar Pascayantri
Asniar Pascayantri
AFAdryan Fristiohady
Adryan Fristiohady
AYAgung Wibawa Mahatva Yodha
Agung Wibawa Mahatva Yodha
SASahidin
Sahidin
Etlingera is a genus that has the potential as a medicinal plant. Etlingera alba (Blume) A.D. Poulsen is an Etlingera species discovered recently in Southeast Sulawesi. This research describes the isolation and discovery of secondary matabolites from the methanol extract of the stem of Etlingera alba (Blume) A.D. Poulsen and is activity test as an antioxidant. Compounds were isolated using chromatography techniques. Identification of the molecular structure of secondary metabolites was carried out bu spectroscopic techniques. The antioxidant test was carried out using the 1,1-dipheny1-2-picrylhydrazyl (DPPH) method. Three diarylheptanoids: yakuchinone A (1), 7-(4”-hydrozy-3”-methoxypheny-1- phenyl-hept-4-en-3-one (2), and oxyphyllacinol (3) have been isolated from the stems of E. alba. Based on the DPPH test, compound 1 showed very strong antioxidant activity with an IC50 value of 26.62µg/ml, wile compounds 2 and 3 showed strong activity with IC50 va;ies pf 73-72 and 63.2µg/ml respectively.

15 March 2025 in Pakistan Journal of Biological Sciences
Verified
Journal Article
Closed access
WWWahyuni Wahyuni
Wahyuni Wahyuni
AFAdryan Fristiohady
Adryan Fristiohady
ISIdin Sahidin
Idin Sahidin
AYAgung Wibawa Mahatva Yo
Agung Wibawa Mahatva Yo
LJLa Ode Muh. Julia
La Ode Muh. Julia
SMSaipul Maulana
Saipul Maulana
Identification of Potential Anticancer Bioactive Compounds from Fractions of Alpinia monopleura Rhizome Extract

31 December 2021 in Jurnal Farmasi Sains dan Praktis
Verified
Journal Article
Open access
PDF file
WWWahyuni Wahyuni
Wahyuni Wahyuni
ADAjeng Diantini
Ajeng Diantini
MGMohammad Ghozali
Mohammad Ghozali
SSSahidin Sahidin
Sahidin Sahidin
Etlingera is one of the plant genera from the Zingiberaceae family and is widely distributed in Asia to the Pacific Islands, with various species ranging from 150 to 200 species. The Etlingera are commonly used as spices, vegetables, and traditional medicines. Many pharmacological activities have been reported from this genus, including antioxidants, antibacterials, cholesterol-lowering, anticancer, and others. The phytochemical content of Etlingera reported are phenolics, diarylheptanoids, flavonoids, steroids, alkaloids, and terpenoids. Eight species from Etlingera, namely Etlingera elatior, E. pavieana, E. brevilabrum, E. pyramidosphaera, E. megalocheilos, E. coccinea, E. fimbriobracteata, and E. corneri are reported provided anticancer activity. This review article aims to review the phytochemical screening from Etlingera genus, and its anticancer activity.

15 January 2026 in Journal of the Turkish Chemical Society Section A: Chemistry
Verified
Journal Article
Open access
AYAgung Wibawa Mahatva Yodha
Agung Wibawa Mahatva Yodha
RRReymon Reymon
Reymon Reymon
NRNirwati Rusli
Nirwati Rusli
AFAngriani Fusvita
Angriani Fusvita
WWWahyuni Wahyuni
Wahyuni Wahyuni
ISIdin Sahidin
Idin Sahidin
Phenolic compounds are widely recognized for their diverse pharmacological properties, including antioxidant, anti-inflammatory, and antidiabetic effects. Alpinia species are known to be rich in bioactive constituents; however, the chemical profile and biological activities of Alpinia monopleura fruit remain poorly explored. This study aimed to isolate, identify, and evaluate the antioxidant, anti-inflammatory, and antidiabetic activities of phenolic compounds from the fruit of A. monopleura. Maceration extraction was carried out using methanol as the solvent, followed by fractionation and purification through chromatographic techniques, resulting in four pure compounds. Structural identification was performed based on ¹H-NMR and ¹³C-NMR spectroscopic data, which were consistent with those reported in reference literature for each compound, namely hexadecyl ferulate (A1), 4-hydroxybenzaldehyde (A2), methyl p-coumarate (A3), and methyl 4-hydroxy-3-methoxybenzoate (A4). Antioxidant activity was evaluated using the DPPH radical scavenging method, anti-inflammatory activity was determined through nitric oxide (NO) inhibition, and antidiabetic activity was assessed using the α-glucosidase inhibition assay. The results showed that all four compounds exhibited biological activities with varying degrees of effectiveness. The IC₅₀ values for the DPPH assay of compounds A1–A4 were 27.60±1.19, 13.52±0.94, 10.30±0.95, and 8.20±0.95 µg/mL, respectively. For NO inhibition, the IC₅₀ values were 42.86±1.08, 16.25±1.06, 11.35±0.96, and 9.69±1.12 µg/mL, while for α-glucosidase inhibition, the IC₅₀ values were 47.39±1.45, 40.67±1.05, 28.59±0.98, and 16.54±0.87 µg/mL, respectively. Methyl 4-hydroxy-3-methoxybenzoate (A4) consistently demonstrated the strongest activity across all assays. These findings confirm that the combination of hydroxyl and methoxy groups plays a crucial role in enhancing the biological activity of phenolic compounds from A. monopleura, suggesting their potential for development as natural bioactive agents.

1 August 2026 in Indonesian Journal of Global Health Research
Verified
Journal Article
Open access
PDF file
NNNurbaida Nurbaida
Nurbaida Nurbaida
WWWahyuni Wahyuni
Wahyuni Wahyuni
HKHenny Kasmawati
Henny Kasmawati
SSSuryani Suryani
Suryani Suryani
RRRuslin Ruslin
Ruslin Ruslin
AFAdryan Fristiohady
Adryan Fristiohady
The management of pharmaceutical supplies in hospitals involves nine interrelated cycles, ranging from planning to disposal. Objective: This study aimed to evaluate drug management practices at RSUD dr. H. L. M. Baharuddin in Muna Regency based on interviews with two key informants, namely the Head of the Pharmacy Installation and the Head of the Pharmacy Warehouse, and to assess compliance with Ministry of Health Regulation No. 72 of 2016. A descriptive design combined with the Hanlon method was employed, using criteria of problem magnitude, seriousness, effectiveness of intervention, and feasibility (PEARL factors). Result: The evaluation showed that most management cycles were adequately implemented; however, significant issues were identified in the storage stage. Key problems included the distance between multiple warehouses, complicating distribution and stock monitoring; the absence of CCTV; and inadequate physical security, such as lack of fencing. Hanlon analysis identified storage issues as the highest priority due to their impact on medication safety, security, and supply continuity. The frequency of incidents, risk of loss, and limited monitoring highlight the need for immediate intervention. Recommended improvements include optimizing storage layout, installing CCTV, strengthening access control, and enhancing physical security in line with national regulations. Although most cycles meet standards, storage management requires immediate improvement.